. It typically inhabits terrestrial plant hosts [1] [2] [3] [4] and has a well-known association with Aruno donax, a garden escape weed known as 'giant reed' or 'elephant grass'. M. arundinis . Is it a coincidence that the first reports of a new mammalian fungal pathogen occurred at virtually the same time, and in the same city, in both human and veterinary (feline) patients?
It may be, but it would neglectful not to look further for factors that may explain why humans and cats were becoming infected by this hitherto non-pathogenic fungus. These events also emphasise the 'One Medicine -One Health' approach to infectious disease investigation, with animals representing sentinels for the occurrence of human disease. This is particularly the case for fungal diseases acquired from the environment. In 2010, our group again reported disease caused by M. arundinis infection affecting the distal extremity of a cat (Figure 1 ), although this animal also had a lesion on its face 4 . Halliday molecularly characterised the internal transcribed spacer (ITS1), 5.8S and ITS2
regions and the D1/D2 region of the 28S rDNA gene cluster of the available human (four) and feline (two) isolates 4, 5 . These included a case (contributed by Tom Gottlieb) of refractory dermal plaques in a renal transplant recipient ( Figure 2 ; Table 1 Table 1 and Figure 2 .
In the veterinary arena, we continue to see M. arundinis infections in cats along the East coast of Australia. It is now probably the most common cause of feline subcutaneous phaeohyphomycosis in this region, with five additional cases between 2009 and 2012 ( Table 2 ).
There does not appear to be any age predisposition in cats (range Histopathological specimens showed pyogranulomatous inflammation ( Figure 3A) , with occasional multi-nucleate giant cell formation.
The organism grows well on routine fungal media such as Sabouraud dextrose agar (containing antibiotics) and microscopically shows irregularly-shaped pigmented septate hyphae, but no conidia.
Since species identification is made difficult by the inability to induce sporulation, PCR amplification and sequence analysis was typically used to establish a specific diagnosis (as outlined above).
This could be done using not only colonial material or fresh biopsy specimens from representative lesions but also paraffin-embedded formalin-fixed tissues In veterinary practice, frustratingly, repeat samples for culture and
antifungal susceptibility are often difficult to obtain. This is usually because serial specimen collection generally requires sedation or anaesthesia with concomitant cost and morbidity. To overcome this potential limitation, we have found that there is sufficient fungal nucleic acid preserved in methanol-fixed, DiffQuik Ò -stained smears to permit successful DNA purification, panfungal PCR and sequence analysis using material scraped from the cytological specimens (Table 2 ). The method 6 , adapted from a similar technique used for diagnosis of veterinary mycobacteria specimens 7 , was successful in 4/4 feline M. arundinis cytology slides in which it was attempted (Table 2) .
Antifungal minimum inhibitory concentration breakpoints have not been determined for this organism, although broth microdilution assays suggest most isolates are susceptible to broad spectrum azoles (itraconazole, voriconazole and posaconazole), amphotericin B and terbinafine, with variable susceptibility to fluconazole and resistance to echinocandins and flucytosine. Clinically, itraconazole, posaconazole, ketoconazole and terbinafine all appear to have good in vivo activity.
As voriconazole causes neurotoxicity in many feline patients 8 , we currently recommend posaconazole to treat M. arundinis infections in cats. Although the drug is expensive, it is palatable, available in a liquid form, has minimal hepatotoxicity (unlike itraconazole) and possesses favourable and reliable pharmacokinetics in this species, where once daily administration with meals is convenient for owners 4 . Terbinafine is probably also a good option for cats, with established pharmacokinetics and inexpensive generic formulations available, but we have no experience to date. Despite long courses of therapy, and in some cases cytoreductive surgery (typically toe amputation), there is a tendency for infections in cats to recur months or years after apparently successful therapy. This does not appear to be the case in human patients. Despite this propensity to recur, the organism seems inherently of low virulence, producing indolent infections without dissemination. This is possibly due to the organism favouring lower temperatures for growth, like many fungal saprophytes. The few well documented human cases reported to date have been cured with monotherapy using a triazole or terbinafine, sometimes combined with debridement or amputation of infected tissues 2, 3 .
We speculate that this infection might be becoming more common due to expansion in the range of 'elephant grass' or expansion of other plant hosts capable of supporting its environmental growth.
The location of lesions on the toes of cats suggests penetrating injury of distal extremities during digging may play a role in disease pathogenesis. For the same reason, it might be expected that cat scratch injuries (typically to the face) might also be contaminated by this organism 9, 10 , as in the case reported by Krockenberger et al. Under the Microscope 
